1. Home
  2. MRVI vs LND Comparison

MRVI vs LND Comparison

Compare MRVI & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • LND
  • Stock Information
  • Founded
  • MRVI 2014
  • LND 2005
  • Country
  • MRVI United States
  • LND Brazil
  • Employees
  • MRVI N/A
  • LND N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • MRVI Health Care
  • LND Consumer Staples
  • Exchange
  • MRVI Nasdaq
  • LND Nasdaq
  • Market Cap
  • MRVI 376.2M
  • LND 376.5M
  • IPO Year
  • MRVI 2020
  • LND 2006
  • Fundamental
  • Price
  • MRVI $3.24
  • LND $3.73
  • Analyst Decision
  • MRVI Hold
  • LND
  • Analyst Count
  • MRVI 9
  • LND 0
  • Target Price
  • MRVI $4.54
  • LND N/A
  • AVG Volume (30 Days)
  • MRVI 1.7M
  • LND 41.6K
  • Earning Date
  • MRVI 11-06-2025
  • LND 11-06-2025
  • Dividend Yield
  • MRVI N/A
  • LND 3.27%
  • EPS Growth
  • MRVI N/A
  • LND N/A
  • EPS
  • MRVI N/A
  • LND 0.25
  • Revenue
  • MRVI $219,830,000.00
  • LND $194,084,753.00
  • Revenue This Year
  • MRVI N/A
  • LND $40.80
  • Revenue Next Year
  • MRVI $7.27
  • LND $5.24
  • P/E Ratio
  • MRVI N/A
  • LND $14.33
  • Revenue Growth
  • MRVI N/A
  • LND 3.73
  • 52 Week Low
  • MRVI $1.67
  • LND $3.49
  • 52 Week High
  • MRVI $8.29
  • LND $4.39
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 50.18
  • LND 47.60
  • Support Level
  • MRVI $3.32
  • LND $3.60
  • Resistance Level
  • MRVI $3.55
  • LND $3.78
  • Average True Range (ATR)
  • MRVI 0.19
  • LND 0.07
  • MACD
  • MRVI -0.04
  • LND 0.00
  • Stochastic Oscillator
  • MRVI 8.82
  • LND 60.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: